SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

BRIEF-Ocugen Announces Publication Of A Comprehensive Review Of Bbv152 In Frontiers In Immunology

BRIEF-Ocugen Announces Publication Of A Comprehensive Review Of Bbv152 In Frontiers In Immunology

Reuters · 09/14/2022 06:33
BRIEF-Ocugen Announces Publication Of A Comprehensive Review Of Bbv152 In Frontiers In Immunology

- Ocugen Inc OCGN.O:

  • OCUGEN ANNOUNCES PUBLICATION OF A COMPREHENSIVE REVIEW OF BBV152 IN FRONTIERS IN IMMUNOLOGY

  • OCUGEN INC - STUDY CONCLUDES THAT BBV152 IS A SUITABLE ALTERNATIVE TO MRNA VACCINES

  • OCUGEN INC - CO HAS NORTH AMERICAN COMMERCIALIZATION RIGHTS FOR BBV152, COMMERCIALIZED AS COVAXIN™

Source text for Eikon: ID:

Further company coverage: OCGN.O


((Reuters.Briefs@thomsonreuters.com;))